The future of antiviral treatments looks promising with advancements in genomics and biotechnology. Researchers are working on developing broad-spectrum antivirals that can target multiple viruses. Additionally, the use of CRISPR technology offers potential in editing viral genomes to halt their replication. Continuous monitoring and research are essential to stay ahead of evolving viral threats.
